Born in Jamaica, West Indies, Dr. Leebert Wright came to Canada in 1951 to study at McGill University.
After graduating, he assumed the position of Clinical Biochemist at the Montreal General Hospital with a cross appointment in the Faculty of Medicine at McGill University. Such arrangements continued after arriving in Toronto, where he held a director level position with a Toronto hospitals and played vital roles in major universities.
Following his M.Sc. in Biochemistry he worked as a biochemist in the Laboratory Centre for Disease Control before going to the University of Toronto to continue his studies in the Department of Pathological Chemistry. His outstanding work won him the Allan Hoffman Memorial Award.
While establishing a enviable career, Dr. Wright became a member of the Canadian Society of Clinical Chemistry (CSCC) where he had the opportunity of his life to work with some of the most outstanding scientists in the country dedicated to improving healthcare in Canada.
In 1971, Dr. Wright became President of the CSCC. His leadership and creative energies were directed towards research and development of a range of reference methods and tests for substances such as cholesterol, testosterone and other chemicals that directly affect the well-being of millions of people across Canada.
He also influenced the standardization of Clinical Chemistry in Canada while Chairman of influential national scientific bodies.
For his contribution to Clinical Chemistry and his advocacy both nationally and internationally the CSCC awarded Dr. Wright its most prestigious award, the Ames Award for outstanding contribution to the field of Clinical Chemistry.
He is also a Fellow of the Canadian Academy of Clinical Biochemists and the National Academy of Clinical Biochemists in the United States.
Although retired, Dr. Wright remains actively engaged not only with the CSCC and a range of community organizations.
After graduating, he assumed the position of Clinical Biochemist at the Montreal General Hospital with a cross appointment in the Faculty of Medicine at McGill University. Such arrangements continued after arriving in Toronto, where he held a director level position with a Toronto hospitals and played vital roles in major universities.
Following his M.Sc. in Biochemistry he worked as a biochemist in the Laboratory Centre for Disease Control before going to the University of Toronto to continue his studies in the Department of Pathological Chemistry. His outstanding work won him the Allan Hoffman Memorial Award.
While establishing a enviable career, Dr. Wright became a member of the Canadian Society of Clinical Chemistry (CSCC) where he had the opportunity of his life to work with some of the most outstanding scientists in the country dedicated to improving healthcare in Canada.
In 1971, Dr. Wright became President of the CSCC. His leadership and creative energies were directed towards research and development of a range of reference methods and tests for substances such as cholesterol, testosterone and other chemicals that directly affect the well-being of millions of people across Canada.
He also influenced the standardization of Clinical Chemistry in Canada while Chairman of influential national scientific bodies.
For his contribution to Clinical Chemistry and his advocacy both nationally and internationally the CSCC awarded Dr. Wright its most prestigious award, the Ames Award for outstanding contribution to the field of Clinical Chemistry.
He is also a Fellow of the Canadian Academy of Clinical Biochemists and the National Academy of Clinical Biochemists in the United States.
Although retired, Dr. Wright remains actively engaged not only with the CSCC and a range of community organizations.
No comments:
Post a Comment